Cerity Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.47M | Buy |
159,863
+578
| +0.4% | +$8.94K | ﹤0.01% | 1116 |
|
|
2025
Q1 | $2.37M | Buy |
159,285
+71,634
| +82% | +$1.07M | ﹤0.01% | 1034 |
|
|
2024
Q4 | $1.2M | Sell |
87,651
-39,420
| -31% | -$542K | ﹤0.01% | 1331 |
|
|
2024
Q3 | $1.81M | Buy |
127,071
+61,271
| +93% | +$871K | ﹤0.01% | 1134 |
|
|
2024
Q2 | $851K | Sell |
65,800
-47,071
| -42% | -$609K | ﹤0.01% | 1298 |
|
|
2024
Q1 | $1.57M | Buy |
112,871
+49,903
| +79% | +$693K | ﹤0.01% | 1079 |
|
|
2023
Q4 | $899K | Sell |
62,968
-4,556
| -7% | -$65K | ﹤0.01% | 1018 |
|
|
2023
Q3 | $1.04M | Buy |
67,524
+7,301
| +12% | +$113K | 0.01% | 743 |
|
|
2023
Q2 | $946K | Sell |
60,223
-2,072
| -3% | -$32.5K | ﹤0.01% | 941 |
|
|
2023
Q1 | $3.54M | Buy |
62,295
+7,304
| +13% | +$415K | 0.01% | 562 |
|
|
2022
Q4 | $858K | Sell |
54,991
-22,936
| -29% | -$358K | 0.01% | 738 |
|
|
2022
Q3 | $1.01M | Buy |
77,927
+24,365
| +45% | +$316K | 0.01% | 516 |
|
|
2022
Q2 | $752K | Buy |
53,562
+21,366
| +66% | +$300K | 0.01% | 616 |
|
|
2022
Q1 | $459K | Buy |
32,196
+13,507
| +72% | +$193K | 0.01% | 609 |
|
|
2021
Q4 | $253K | Buy |
18,689
+4,904
| +36% | +$66.4K | ﹤0.01% | 844 |
|
|
2021
Q3 | $226K | Sell |
13,785
-34
| -0.2% | -$557 | 0.01% | 626 |
|
|
2021
Q2 | $233K | Sell |
13,819
-882
| -6% | -$14.9K | 0.01% | 647 |
|
|
2021
Q1 | $268K | Sell |
14,701
-13,978
| -49% | -$255K | 0.01% | 579 |
|
|
2020
Q4 | $522K | Buy |
28,679
+725
| +3% | +$13.2K | 0.02% | 404 |
|
|
2020
Q3 | $499K | Hold |
27,954
| – | – | 0.02% | 320 |
|
|
2020
Q2 | $501K | Buy |
27,954
+9,346
| +50% | +$168K | 0.03% | 280 |
|
|
2020
Q1 | $282K | Buy |
18,608
+546
| +3% | +$8.28K | 0.02% | 352 |
|
|
2019
Q4 | $356K | Buy |
18,062
+884
| +5% | +$17.4K | 0.02% | 395 |
|
|
2019
Q3 | $295K | Sell |
17,178
-3,659
| -18% | -$62.8K | 0.02% | 393 |
|
|
2019
Q2 | $369K | Sell |
20,837
-4,929
| -19% | -$87.3K | 0.02% | 364 |
|
|
2019
Q1 | $525K | Buy |
+25,766
| New | +$525K | 0.04% | 317 |
|